As one of the world's largest ethnic populations, Han Chinese have been included in HapMap SNP mapping projects and 1000 Genomes projects for variant discovery. Compared with American and European populations, however, Han Chinese populations are significantly under represented in genome-wide association studies (GWAS). Since 2008, only 13 GWAS related to psychiatric disorders or traits that included individuals of Chinese descent have been published. Listed in Table 1 , these studies focused on schizophrenia, subtypes of schizophrenia, schizophrenia-related traits, bipolar disorder 1 or autism. 2 The largest of these studies included several thousand samples. By contrast, during the same period about 256 GWAS were published on psychiatric diseases or traits (including addiction, sleep and eating disorders, behavior and brain structure, connectivity, and treatment responses) outside of China, primarily in Europe and the United States (GWAS Catalog 3 ). The largest international psychiatric genetics research consortium, the Psychiatric Genomics Consortium (PGC; http:// www.med.unc.edu/pgc) 4 has analyzed 4150 000 cases and controls, primarily of European descent. 5 Other examples of successful international collaborations include the ENIGMA consortium (http://enigma.ini.usc.edu/) 6 the Consortium on Lithium Genetics (www.ConLiGen.org), 7 Consortium on the Genetics of Schizophrenia (COGS), 8 and Project among African-Americans to Explore Risks for Schizophrenia (PAARTNERS). 9 
SUCCESSFUL PSYCHIATRIC GENETICS REQUIRES LARGE COLLABORATIVE CONSORTIA AND DATA SHARING
The success of the PGC in identifying novel genetic variants and biological pathways that contribute to psychiatric disorders 
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clearly demonstrates the importance of large sample sizes for detecting disease associations for genetic variants of modest effect. 5, [10] [11] [12] In addition, successful genetic studies require the careful ascertainment and characterization of cases and controls and the implementation of uniform genotyping methods and strict data quality control. It is difficult for a single research group, let alone a single researcher, to shoulder all of these tasks.
As may be expected, the small number of GWAS carried out by individual labs or small sets of labs in China have yielded few definitive results. For example, a study by Yue et al. 13 reported schizophrenia associations at 11p11.2 and the MHC region and a study by Shi et al.
14 reported schizophrenia associations at 8p12 and 1q24.2, but these findings were not replicated in an independent study. 15 The inability to replicate genetic associations is a common problem in genetic studies of complex diseases and is often caused by extensive genetic and/or phenotypic heterogeneity, or sample sizes with insufficient power to detect the associations. These obstacles can be overcome with more selective ascertainment, improved phenotyping, and larger numbers of cases and controls. Clearly more cooperation among research groups and increased funding to support collaborative research within China will be essential to achieve these goals. The first steps in this direction have been taken through a few between-lab collaborations such as those initiated by Hong Kong and Sichuan, Changsha and Shanghai, or Changsha and Kunming investigators. These activities have produced joint publications, including several listed in Table 1 .
In addition to direct lab-to-lab collaborations, sharing data more broadly would be another effective way to boost productivity. Again, meta-analyses carried out by PGC and other groups have repeatedly demonstrated the power of combining data from multiple sources. 16, 17 The United States National Institutes of Health (NIH) has established policies requiring data sharing in its funding agreements for big grants, and these have been influential toward changing the culture of the genetics research community. There is currently no similar culture or infrastructure to support data sharing in China. This problem has been discussed in the field, however, and there are now several initiatives to foster collaboration and data sharing, such as the Strategic Priority Research Program of Chinese Academy of Sciences. 18 
PSYCHIATRIC GENETICS IN CHINA NEEDS MORE FUNDING
In recent decades, the Chinese government has steadily increased investments in science and technology, but investments in basic research are still smaller in terms of the percentage of total research and development spending than in most developed countries, including Japan and South Korea. 19 The NIH alone funded 156 new studies involving psychiatric genetics in 2012 and 2013, primarily through the NIMH, NIDA and NIAAA (Supplementary Table 1 The Chinese government has also been planning similar projects and Chinese Brain Project is currently on track. Whether psychiatric genetics will benefit from this initiative, remains to be seen. From a scientific point of view, genetics is essential to understanding the origins of brain structure and function and the causes of brain disorders. It is unlikely that we will be able to fully understand mental illness without an understanding of its genetic underpinnings.
ADMINISTRATIVE POLICIES ARE CRITICAL TO PROMOTE COLLABORATIVE RESEARCH
In addition to increasing monetary support for research on the genetics of psychiatric disorders, it is essential that funding and administrative agencies in China develop policies that promote collaborative research. As collaborative structures challenge traditional methods for evaluating the contributions of individual researchers, creative solutions are needed to guarantee that individuals and their academic institutions receive appropriate recognition. If such solutions are not in place, the success of large consortia, and thus the success of the field as a whole, will be jeopardized by the unwillingness of researchers to share data or expertise.
Unfortunately, structural impediments to collaboration are still in place in China, where researchers typically receive credit only for those publications on which they are listed as the first or communicating author and their respective institution and academic department also listed first. Determining how to properly share credit and assign a balanced weight to each contributor's contributions, regardless of the exact position of the contributor's name in the authors' list, are key elements of successful collaborations. The recent trend for journals to require authors to state their individual contributions to the research is a step in the right direction, but additional measures are needed to make sure that individuals are not penalized for participating in collaborative projects. Since the ultimate goal of research is to improve people's health and welfare, it is imperative that university administrations and government agencies work with the research community to eliminate disincentives currently embedded in policies governing the evaluation of research and allocation of funds.
CHALLENGES AND OPPORTUNITIES FOR PSYCHIATRIC GENETICS RESEARCH IN CHINA
Concerning directions for future research on psychiatric genetics, it is likely that success in elucidating the genetic basis of psychiatric disorders will hinge upon the: (i) ascertainment of large, carefully and deeply phenotyped sets of families, cases and controls for each disorder, (ii) use of advanced genome-level experimental techniques, including second-and third-generation DNA sequencing technologies and advanced methods for the analysis of all kinds of 'omics' data, and (iii) development of powerful statistical and bioinformatic tools to handle 'big data'. Many of the required experimental tools are currently in use by the United States and European researchers and can be rapidly adapted to analyze Chinese samples. If realized, these efforts will generate Han Chinese-specific maps of genetic, epigenetic and functional variation, including molecular quantitative trait loci (expression (e)QTL, methylation (m)QTL and so on), similar to those produced by the ENCODE, 21 GTEx 22 and, most recently, PsychENCODE projects primarily for Caucasian populations. Genome-level resources are rapidly becoming indispensable for genetic research and detailed information on the Chinese population would greatly facilitate the identification of liability and protective genetic variants that are common in or unique to the Chinese population. Creating these resources will be a crucial step toward developing personalized precision medicine in China.
Although China currently lags behind the United States and Europe in funding and volume of research in psychiatric genetics, much of the technical expertise and human resources needed to support cutting-edge research in this field are already in place. For example, DNA samples from some of the largest studies on Caucasian populations are now being genotyped or sequenced in Shenzhen or Hong Kong. In addition, several Chinese research groups are currently conducting small-scale exome-and whole genome-sequencing projects, including several exomesequencing projects focusing on schizophrenia or autism. Individual laboratories have also established short-or long-term collaborations as a means to leverage expertise and resources, often with advance agreements to alternate principal authorships on papers published together. China also has exceptional strength and depth in the areas of statistics, bioinformatics and computer science owing to a highly competitive education system. GWAS and next-generation sequencing-based studies of complex genetic disorders require very large numbers of samples (for example, 410K cases and controls) to achieve sufficient statistical power. In addition, precise and expanded phenotyping is needed to identify endophenotypes or disorder subtypes that may be more tractable to genetic analysis. Fortunately, clinical departments in academically affiliated hospitals in China are often willing to commit resources to the ascertainment and clinical evaluation of subjects for genetic studies to improve their national ranking. Refined phenotyping, including structural and functional brain imaging, is becoming increasingly important in psychiatric research. Imaging technologies are also now widely available in China and the costs are usually considerably lower compared to the United States and Europe. Recently, several brain imaging investigators have begun publishing papers in the field of mental health. 23, 24 An overview of endophenotyping studies in China is given by Chan et al. (2010) . 25 To date, the genetics of only several psychiatric disorders, including schizophrenia, autism and bipolar disorder have been studied in China. Clearly, there is need to expand these studies to include additional mental illnesses, such as attention-deficit hyperactivity disorder (ADHD), major depression and drug addiction. Even for disorders that have been covered, the numbers of individuals recruited into genetic studies are disproportionately small compared with the sizes of patient populations in China. Public awareness of psychiatric disorders and research, education, and physicians' participation will be crucial to improve the current situation. Of particular importance is the need to increase access to mental health care for the large number of individuals in China with undiagnosed and/or untreated mental illness. 26, 27 Including these individuals in research studies may help publicize their plight and thereby improve access to mental health services.
Historically, international collaboration has had a crucial role in the advancement of science. Strict regulations governing the export of biological samples from China, however, has created barriers for some international collaborations, although it does offer protection against unequal collaborations in which Chinese partners only serve as sample suppliers, with limited intellectual contributions and credit. Hopefully, with the development of psychiatric genetics in China, more mutually beneficial collaborations can be approved by the Chinese government. In such collaborations, investigators from underdeveloped regions in China should gain not only credit in publications, but most importantly acquire training, skills, knowledge and resources to support future studies. Chinese scientists should work with government administrators to update and revise regulations based on recent developments in the field. Whereas international collaborations including Chinese partners may require extra efforts to establish, they are nonetheless feasible, as advanced experiments can now be carried out professionally in China.
Studies of post-mortem human brains have significantly contributed to our understanding of the biology of psychiatric disorders, and it will continue to be important for acquiring and integrating genetic, genomic and epigenomic data relevant to these disorders. Collecting post-mortem brains has been a challenging task worldwide, even more so in China, where individuals and relatives are reluctant to donate body tissues for cultural reasons. Currently, there is a single source for postmortem brain tissue in mainland China: the Chinese Brain Bank Center (CBBC, http://cbbc.scuec.edu.cn) in Wuhan, which was established in 2007 and receives limited support from government funding agencies. To date, CBBC has acquired and carefully preserved several hundred brains, primarily obtained through medical autopsies and following stringent consent procedures. The collection, however, still lacks brains from individuals with well-documented psychiatric disorders. Clearly, psychiatric genetics research in China would benefit from an expanded program for the acquisition of both normal and pathological samples, as well as from sharing samples and expertise from brain banks outside of China. Key to achieving this goal will be additional government funding and, importantly, expanded public education and outreach programs.
Another important approach to understanding the genetic basis of psychiatric disorders is through studies of divergent populations, since genetic drift and regional selection may produce population-specific differences in allele frequencies and linkage disequilibrium patterns for liability and protective genetic variants. For example, a recent study showed that CREB1 carries risk alleles that are present at moderate frequencies in Europeans, but are generally absent in Africans and East Asians. The high frequencies of these alleles among Europeans may be the result of genetic 'hitchhiking' due to natural selection acting on a nearby gene in the European population. 28 Frequencies of diseaseassociated variants may thus vary significantly between Chinese and European populations. Genetic association studies that incorporate information concerning the evolutionary histories of genes and populations should enhance our understanding of the genetic heterogeneity commonly observed in psychiatric disorders.
In addition to untapped opportunities in human genetics, China also has rich resources for studies on nonhuman primates. China is currently the leading producer and major supplier of experimental primates for developed countries, including the United States, and researchers from China have established a number of primate animal models for human brain diseases. 29 Leading primate research facilities in China include the Kunming Primate Research Center of Chinese Academy of Sciences, Kunming Institute of Zoology, which has received international recognition. 30, 31 The Research Center is well equipped and capable of supporting cutting-edge genetic research.
Another area where China may have special advantages is in the exploration and testing of herbal treatments for psychiatric diseases, an approach that falls within scope of traditional Chinese medicine and has not been extensively studied in Western countries. The implementation of well-designed studies of drug efficacy and impact on biomarkers of diseases should help us better understand the potential of alternative treatments. Herein may be found many opportunities for discoveries that lie beyond well-trodden paths. 32 Clearly, the study of psychiatric genetics in Chinese populations should not be the exclusive province of investigators working in mainland China. Indeed, many researchers from Hong Kong, Taiwan, Singapore, Europe and North America have actively participated in psychiatric genetic studies of Chinese populations during the past decade. To foster collaborations, there is a definite need for a large scientific society built on shared interests and trust among colleagues. Such a society would promote public awareness, collaborative research, training, and data sharing and establish standards for experimental design and academic performance.
SUMMARY
Psychiatric genetics is still in its early stages in China, but has great potential and a promising future. Many of the elements and resources required for the dynamic growth of this field are already in place. At the same time, there are many hurdles to overcome. Enhanced education to promote public awareness of the importance of genetic research, increased funding for individual labs and collaborative research, increased participation of clinicians in patient ascertainment and testing, and improved academic evaluation policies are all vital to fostering collaborative research and the formation of large consortia needed to create a science of genetics tailored to the needs of the Chinese population. We hope that collaborative efforts of the entire psychiatric genetics community, with active input from the researchers who are working on neuroscience biology, will lead to better ways of diagnosing, treating and preventing psychiatric diseases in China, thereby easing the burdens of individual sufferers and their families and the social and economic burdens of country as a whole.
The ideas discussed at the First Summit on Chinese Psychiatric Genetics in 2004 were further developed at the Second Summit on Chinese Psychiatric Genetics in Kunming, Yunnan (12-13 April) and presentations and discussions from both Summits contributed to the content of the present paper. The Third Summit on Chinese Psychiatric Genetics will be held in Wuxi, Jiangsu in 2016. We strongly believe that these Summits will become an important forum for psychiatric genetics research in China and will serve as a seed from which a new research society will grow. We welcome all interested researchers, both international and from China, to join us at our next meeting in Wuxi.
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